Updated Jul 16, 2026
Madigan Catherine has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Catherine Madigan is an executive associated with Hemab Therapeutics Holdings, Inc., a biotechnology company focused on developing therapies for rare bleeding disorders. Specific details about her role and contributions to the company are limited in publicly available sources.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Catherine Madigan is an executive associated with Hemab Therapeutics Holdings, Inc., a biotechnology company focused on developing therapies for rare bleeding disorders. Specific details about her role and contributions to the company are limited in publicly available sources.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Madigan Catherine profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.